369 related articles for article (PubMed ID: 31406672)
1. Engineering Cell Membrane-Based Nanotherapeutics to Target Inflammation.
Yan H; Shao D; Lao YH; Li M; Hu H; Leong KW
Adv Sci (Weinh); 2019 Aug; 6(15):1900605. PubMed ID: 31406672
[TBL] [Abstract][Full Text] [Related]
2. Coating nanoparticles with cell membranes for targeted drug delivery.
Gao W; Zhang L
J Drug Target; 2015; 23(7-8):619-26. PubMed ID: 26453159
[TBL] [Abstract][Full Text] [Related]
3. Bioengineering CXCR4-overexpressing cell membrane functionalized ROS-responsive nanotherapeutics for targeting cerebral ischemia-reperfusion injury.
Luo L; Zang G; Liu B; Qin X; Zhang Y; Chen Y; Zhang H; Wu W; Wang G
Theranostics; 2021; 11(16):8043-8056. PubMed ID: 34335979
[No Abstract] [Full Text] [Related]
4. Recent Advances of Engineered Cell Membrane-Based Nanotherapeutics to Combat Inflammatory Diseases.
Ma J; Ding L; Peng X; Jiang L; Liu G
Small; 2024 Feb; ():e2308646. PubMed ID: 38334202
[TBL] [Abstract][Full Text] [Related]
5. siRNA-based nanotherapeutics as emerging modalities for immune-mediated diseases: A preliminary review.
Sargazi S; Arshad R; Ghamari R; Rahdar A; Bakhshi A; Karkan SF; Ajalli N; Bilal M; Díez-Pascual AM
Cell Biol Int; 2022 Sep; 46(9):1320-1344. PubMed ID: 35830711
[TBL] [Abstract][Full Text] [Related]
6. Tumor microenvironment targeted nanotherapeutics for cancer therapy and diagnosis: A review.
Thakkar S; Sharma D; Kalia K; Tekade RK
Acta Biomater; 2020 Jan; 101():43-68. PubMed ID: 31518706
[TBL] [Abstract][Full Text] [Related]
7. Extracellular vesicle-based Nanotherapeutics: Emerging frontiers in anti-inflammatory therapy.
Tang TT; Wang B; Lv LL; Liu BC
Theranostics; 2020; 10(18):8111-8129. PubMed ID: 32724461
[TBL] [Abstract][Full Text] [Related]
8. Drug Targeting
Wang S; Duan Y; Zhang Q; Komarla A; Gong H; Gao W; Zhang L
Small Struct; 2020 Oct; 1(1):. PubMed ID: 33817693
[TBL] [Abstract][Full Text] [Related]
9. Cell membrane biomimetic nanoparticles for inflammation and cancer targeting in drug delivery.
Wang H; Liu Y; He R; Xu D; Zang J; Weeranoppanant N; Dong H; Li Y
Biomater Sci; 2020 Jan; 8(2):552-568. PubMed ID: 31769765
[TBL] [Abstract][Full Text] [Related]
10. Recent progress in therapeutic strategies and biomimetic nanomedicines based on neutrophils for inflammation treatment.
Liu Y; Yu Y; Wang M; Zhang C; Li C
Nanomedicine (Lond); 2023 Feb; 18(5):485-500. PubMed ID: 37165973
[TBL] [Abstract][Full Text] [Related]
11. Modulating the tumor microenvironment with new therapeutic nanoparticles: A promising paradigm for tumor treatment.
Zhang Y; Ho SH; Li B; Nie G; Li S
Med Res Rev; 2020 May; 40(3):1084-1102. PubMed ID: 31709590
[TBL] [Abstract][Full Text] [Related]
12. Cell Membrane-Cloaked Nanotherapeutics for Targeted Drug Delivery.
Lee NH; You S; Taghizadeh A; Taghizadeh M; Kim HS
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216342
[TBL] [Abstract][Full Text] [Related]
13. Immune cell-camouflaged surface-engineered nanotherapeutics for cancer management.
Jain N; Shahrukh S; Famta P; Shah S; Vambhurkar G; Khatri DK; Singh SB; Srivastava S
Acta Biomater; 2023 Jan; 155():57-79. PubMed ID: 36347447
[TBL] [Abstract][Full Text] [Related]
14. Orchestration of biomimetic membrane coating and nanotherapeutics in personalized anticancer therapy.
Chen X; Liu B; Tong R; Zhan L; Yin X; Luo X; Huang Y; Zhang J; He W; Wang Y
Biomater Sci; 2021 Feb; 9(3):590-625. PubMed ID: 33305765
[TBL] [Abstract][Full Text] [Related]
15. Improved Targeting of Cancers with Nanotherapeutics.
Foster C; Watson A; Kaplinsky J; Kamaly N
Methods Mol Biol; 2017; 1530():13-37. PubMed ID: 28150194
[TBL] [Abstract][Full Text] [Related]
16. Biomimetic nanotherapeutics: Employing nanoghosts to fight melanoma.
Bagasariya D; Charankumar K; Shah S; Famta P; Khatri DK; Singh Raghuvanshi R; Bala Singh S; Srivastava S
Eur J Pharm Biopharm; 2022 Aug; 177():157-174. PubMed ID: 35787429
[TBL] [Abstract][Full Text] [Related]
17. Emerging Nanotherapeutic Approaches to Overcome Drug Resistance in Cancers with Update on Clinical Trials.
Bukhari SNA
Pharmaceutics; 2022 Apr; 14(4):. PubMed ID: 35456698
[TBL] [Abstract][Full Text] [Related]
18. Amelioration of ulcerative colitis
Sun T; Kwong CHT; Gao C; Wei J; Yue L; Zhang J; Ye RD; Wang R
Theranostics; 2020; 10(22):10106-10119. PubMed ID: 32929337
[TBL] [Abstract][Full Text] [Related]
19. Engineered multifunctional nanocarriers for controlled drug delivery in tumor immunotherapy.
Katopodi T; Petanidis S; Tsavlis D; Anestakis D; Charalampidis C; Chatziprodromidou I; Eskitzis P; Zarogoulidis P; Kosmidis C; Matthaios D; Porpodis K
Front Oncol; 2022; 12():1042125. PubMed ID: 36338748
[TBL] [Abstract][Full Text] [Related]
20. Tumor microenvironment-activated cancer cell membrane-liposome hybrid nanoparticle-mediated synergistic metabolic therapy and chemotherapy for non-small cell lung cancer.
Zhang W; Gong C; Chen Z; Li M; Li Y; Gao J
J Nanobiotechnology; 2021 Oct; 19(1):339. PubMed ID: 34689761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
